GENEVA, Jan. 20 -- HARPOON THERAPEUTICS, INC. (126 East Lincoln AvenueRahway, New Jersey 07065) filed a patent application (PCT/US2025/036581) for "TROP2 TARGETING TRISPECIFIC PROTEIN FOR TREATMENT OF CANCER" on Jul 07, 2025. With publication no. WO/2026/015418, the details related to the patent application was published on Jan 15, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): WESCHE, Holger (1080 Jamestown AvenueSan Francisco, California 94124), LIN, Shuoyen Jack (2350 Evergreen DriveSan Bruno, California 94066), WRIGHT, Kevin J. (2127 Pullman AvenueBelmont, California 94002), AUSTIN, Ric...